Olympus Corporation, a global medtech company headquartered in Japan, has announced the launch of VISERA S, the all-in-one imaging platform with stroboscopy. The new video platform integrates advanced diagnostic capabilities, including NBI (Narrow Band Imaging) technology, and forms part of the expanding Ear, Nose and Throat (ENT) solution from Olympus.

The company will first launch VISERA S from September 2024 in Europe and parts of Asia and Oceania. VISERA S will later be introduced in other regions after product registration has been approved by the local regulatory bodies.

Designed to help improve ENT diagnostic efficiency and patient experience, VISERA S offers an integrated video diagnosis system that brings NBI to a range of patient settings, from outpatient offices to private practices. With VISERA S, the clinician can switch between white light, NBI and stroboscopy capabilities and use the sharp HD quality visualization to detect, characterise and treat ENT disease.

VISERA S, with its improved colour resolution, depth of field and minimised noise, is expected to improve the contrast and visibility of vascular structures and mucosa.

Enhancing Olympus’ commitment to continuous diagnostic and patient-centered innovation, VISERA S supports a HD camera head, which provides higher image quality than the legacy video platform. VISERA S is also highly adaptable by being compatible with other Olympus scopes, camera heads, monitors and other existing video equipment.